Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation
Open Access
- 1 February 2001
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 27 (3) , 341-343
- https://doi.org/10.1038/sj.bmt.1702766
Abstract
Four patients with AL amyloidosis underwent high-dose chemotherapy and autologous stem cell transplantation at our institutions. Here, we report the clinical courses and outcomes in these patients. Two patients with multi-organ amyloid deposits including cardiac involvement died within 12 days after high-dose chemotherapy. However, in the other two patients, one of whom was suffering from amyloid-related cardiac failure, a significant improvement of organ function was achieved. Bone Marrow Transplantation (2001) 27, 341–343.Keywords
This publication has 9 references indexed in Scilit:
- Autologous stem cell transplantation for AL amyloidosis: a standard therapy?Leukemia, 1999
- High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplantBone Marrow Transplantation, 1999
- Intermediate‐dose intravenous melphalan and blood stem cells mobilized with sequential GM+G‐CSF or G‐CSF alone to treat AL (amyloid light chain) amyloidosisBritish Journal of Haematology, 1999
- Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathyAmerican Heart Journal, 1998
- Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsBritish Journal of Haematology, 1998
- A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and ColchicineNew England Journal of Medicine, 1997
- Incidence and Impact of Light Chain Associated (AL) Amyloidosis on the Prognosis of Patients with Multiple Myeloma Treated with Autologous TransplantationLeukemia & Lymphoma, 1997
- High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement [letter]Blood, 1996